Drug Shortage Report for SDZ CELECOXIB
| Report ID | 111341 |
| Drug Identification Number | 02442647 |
| Brand name | SDZ CELECOXIB |
| Common or Proper name | Celecoxib |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CELECOXIB |
| Strength(s) | 200MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | M01AH |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-03 |
| Estimated end date | Unknown |
| Actual end date | 2020-04-01 |
| Shortage status | Avoided shortage |
| Updated date | 2023-11-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-11-17 | French | Compare |
| v3 | 2023-11-17 | English | Compare |
| v2 | 2020-04-07 | French | Compare |
| v1 | 2020-04-07 | English | Compare |
Showing 1 to 4 of 4